<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Interdiscip Perspect Infect Dis</journal-id><journal-id journal-id-type="publisher-id">IPID</journal-id><journal-title-group><journal-title>Interdisciplinary Perspectives on Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1687-708X</issn><issn pub-type="epub">1687-7098</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19259326</article-id><article-id pub-id-type="pmc">2648626</article-id><article-id pub-id-type="doi">10.1155/2008/314762</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Combining Microarray Technology and Molecular Epidemiology to Identify Genes Associated with Invasive Group B <italic>Streptococcus</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lixin</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Reddi</surname><given-names>Usha</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Srinivasan</surname><given-names>Usha</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Sheng</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Borchardt</surname><given-names>Stephanie M.</given-names></name><xref ref-type="aff" rid="I1"><sup>1, 3</sup></xref><xref ref-type="aff" rid="I3"/></contrib><contrib contrib-type="author"><name><surname>Pillai</surname><given-names>Parvathy</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Puja</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Styka</surname><given-names>Anne N.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>DeBusscher</surname><given-names>Joan</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marrs</surname><given-names>Carl F.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Foxman</surname><given-names>Betsy</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA</aff><aff id="I2"><sup>2</sup>Program in Bioinformatics, Eastern Michigan University, Ypsilanti, MI 48197, USA</aff><aff id="I3"><sup>3</sup>Fargo VA Medical Center, Fargo, ND 58102, USA</aff><author-notes><corresp id="cor1">*Lixin Zhang: <email>lxzhang@umich.edu</email></corresp><fn fn-type="other"><p>Recommended by Joshua P. Metlay</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>25</day><month>2</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>314762</elocation-id><history><date date-type="received"><day>29</day><month>8</month><year>2007</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Lixin Zhang et al.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Many bacterial species function as both commensals and pathogens; we used this dual nature to develop a high-throughput molecular epidemiological approach to identifying bacterial virulence genes.  We applied our approach to Group B <italic>Streptococcus</italic>  (GBS).  Three representative commensal and one invasive GBS isolates were selected as tester strains from a population-based collection.  We used microarray-based comparative genomic hybridization to identify open reading frames (ORFs) present in two sequenced invasive strains, but absent or divergent in tester strains.  We screened 23 variable ORFs against 949 GBS isolates using a GBS Library on a Slide (LOS) microarray platform. Four ORFs occurred more frequently in invasive than commensal isolates, and one appeared more frequently in commensal isolates.  Comparative hybridization using an oligonucleotide microarray, combined with epidemiologic screening using the LOS microarray platform, enabled rapid identification of bacterial genes potentially associated with pathogenicity.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Group B <italic>Streptococcus</italic> (GBS), or <italic>Streptococcus agalactiae</italic>, a common bowelinhabitant,  also frequently colonizes the vagina, urethra, and pharynxasymptomatically.  However, GBS can causea variety of invasive diseases that occur primarily in neonates, young infants,elderly persons, and pregnant women [<xref ref-type="bibr" rid="B11">1</xref>&#x02013;<xref ref-type="bibr" rid="B40">3</xref>].  Host factors are clearly important as GBSdisease occurs primarily in vulnerable populations.  Nonetheless, bacterial virulence factors mustalso play a role: propensity to cause disease varies by serotype [<xref ref-type="bibr" rid="B10">4</xref>], andgenetic sequence types that cross serotype, which have a high potential tocause invasive disease, have been identified [<xref ref-type="bibr" rid="B22">5</xref>].</p><p>Amongthe nine known GBS capsular serotypes, serotypes Ia, III, and V cause themajority of GBS disease in the United States  [<xref ref-type="bibr" rid="B11">1</xref>, <xref ref-type="bibr" rid="B16">6</xref>&#x02013;<xref ref-type="bibr" rid="B48">8</xref>].  Studies of the population structure and the molecularepidemiology of GBS isolates suggest that GBS populations are clonal, but thatsome strains may be more virulent than others [<xref ref-type="bibr" rid="B5">9</xref>&#x02013;<xref ref-type="bibr" rid="B42">13</xref>].  By pulsed-field gel electrophoresis (PFGE),disease-causing isolates have limited heterogeneity within a serotype (reviewedin Schuchat, 1998 [<xref ref-type="bibr" rid="B39">2</xref>]) while colonizing isolates are quite heterogeneous [<xref ref-type="bibr" rid="B18">14</xref>]within a particular serotype, suggesting that invasive isolates have distinctivefeatures which enhance pathogenesis. Differences in virulence are likely related to the presence or absenceof virulence genes [<xref ref-type="bibr" rid="B1">15</xref>].  Althoughadvances have been made in the understanding of classic GBS traits, such ascapsular polysaccharide, <italic>&#x003b2;</italic>-hemolysin, C5a peptidase, and immunogenic surfaceproteins [<xref ref-type="bibr" rid="B19">16</xref>&#x02013;<xref ref-type="bibr" rid="B34">19</xref>], our understanding of the pathogenesis of GBSinfections is limited: little is known about which bacterial genetic factorscontribute to virulence or transmission of pathogenic strains.</p><p>Theavailability of complete and draft genome sequences of several GBS strains presentsan opportunity to gain insight into the molecular basis of GBS virulence.  Analysis of these genome sequences confirmeda high level of genetic heterogeneity among GBS strains, even of the sameserotype [<xref ref-type="bibr" rid="B44">20</xref>].  The GBS genome contains alarge number of genetic islands that often vary among strains and are likely tobe the regions where virulence genes reside [<xref ref-type="bibr" rid="B14">21</xref>&#x02013;<xref ref-type="bibr" rid="B45">23</xref>].  With thousands of genes identified in GBSgenomes, the current challenge is to determine which are important in GBSpathogenesis and transmission.  In aprevious study of <italic>E. coli</italic>, wepresented an approach of bacterial gene identification and evaluation thatrelied on epidemiologic information for selecting isolates for genomicsubtraction and screening of epidemiologically defined collections forevaluation of the significance of genes identified through genomic subtraction[<xref ref-type="bibr" rid="B50">24</xref>].  In this report, we applied thesame principle in a three-step strategy to the study of GBS.  Further, we employed novel microarrayplatforms that enabled us to systematically identify candidate genes andevaluate their importance on a large scale.</p><p>Genomecomparison between pathogenic and nonpathogenic strains within a species is apowerful strategy for identifying candidate genes important for virulence [<xref ref-type="bibr" rid="B38">25</xref>, <xref ref-type="bibr" rid="B46">26</xref>].  Since none of the currently sequenced GBSgenomes are from commensal isolates, we first selected a few representativecolonizing GBS strains from a population-based sample for comparisons withsequenced pathogenic serotype III strain (NEM316) and serotype V strain(2306VR), two serotypes representing the most frequently encountered disease-causingisolates.  We then identified sequence differencesand their associated variable genes between selected colonizing and sequencedinvasive GBS strains using comparative genomic hybridization with fine-tilingoligonucleotide microarrays.  Lastly, aselected set of variable genes was screened against a large panel of colonizingand invasive strains using Library on a Slide microarray to evaluate theirassociation with disease.  Our mainobjective of this report is to use GBS as an example to demonstrate andevaluate this study approach.</p></sec><sec sec-type="section" id="sec2"><title>2. MATERIALS AND METHODS</title><sec sec-type="subsection" id="sec2.1"><title>2.1. Bacterial strains and culture conditions</title><p>Disease-causingand commensal GBS isolates were selected from various collections obtained fromprevious epidemiologic studies. Collections included isolates from healthy male and nonpregnant femalecollege students enrolled at the University of Michigan [<xref ref-type="bibr" rid="B6">27</xref>&#x02013;<xref ref-type="bibr" rid="B29">30</xref>],isolates from symptomatic and asymptomatic pregnant women seen at a Universityof Michigan Medical Center clinic [<xref ref-type="bibr" rid="B27">31</xref>], and isolates collected from patientsthrough the Wisconsin Invasive Bacterial Laboratory Surveillance System between1998 and 2002 [<xref ref-type="bibr" rid="B9">32</xref>].  Additional isolatesfrom newborns in Texas with early and late onset disease [<xref ref-type="bibr" rid="B48">8</xref>]  as well asisolates from pregnant women with and without GBS disease were obtained fromDr. Carol J. Baker (Baylor College of Medicine, Houston, Texas, USA).  Thesestrains were broadly grouped into two categories: invasive isolates frompatients with invasive diseases (<italic>n</italic> = 386) and colonizing isolates from subjectswithout any symptomatic diseases (<italic>n</italic> = 563). GBS strain NEM316 [<xref ref-type="bibr" rid="B14">21</xref>], 2603VR [<xref ref-type="bibr" rid="B45">23</xref>], and A909 [<xref ref-type="bibr" rid="B25">33</xref>] were used asreference strains.  GBS isolates werecultured overnight in Todd-Hewitt broth (Oxoid) for DNA isolation.</p></sec><sec sec-type="subsection" id="sec2.2"><title>2.2. PFGE and capsular typing</title><p>PFGE was performed asdescribed previously [<xref ref-type="bibr" rid="B29">30</xref>].  Briefly, GBSDNA was digested with <italic>Sma</italic>I andelectrophoresed for 18 hours (initial switch time 4 seconds; final switch time 16seconds) with the CHEF III apparatus (Bio-Rad, Hercules, CA).  Gels were strained for 4 h with Vistra Green(Amersham Biosciences, Piscataway, NJ, USA) at 4 C, and visualized with a StormPhosphorImager (Amersham Biosciences, Piscataway, NJ, USA).  PFGE patterns were analyzed using BioNumericsoftware (Applied Maths, Kortrijk, Belgium).  A dendrogram was constructed using theunweighted pair group method with arithmetic means, Dice coefficient, optimizationsetting of 1.0%, and a position tolerance of 1.0%.  GBS isolates were classified into capsulartypes Ia, Ib, and II&#x02013;VIII using DNA dot blot hybridization, as previouslydescribed [<xref ref-type="bibr" rid="B8">34</xref>].</p></sec><sec sec-type="subsection" id="sec2.3"><title>2.3. GBS oligonucleotide microarray construction</title><p>Twofine-tiling oligonucleotide microarrays were designed using the published DNAsequences for serotype III strain (NEM 316, GenBank accession no. AL732656) andserotype V strain (2603VR, GenBank accession no. AE009948).  The NEM 316 array consisted of a total of368,576 32-mer probes (184,288 pairs) tiling its 2.21 Mb genome every 12 basesfor both strands.  The 2603VR arrayconsisted of a total 360,040 32-mer probes (180,020 pairs) tiling its 2.16 Mbgenome every 12 bases for both strands. Arrays were designed and constructed through custom Array CGH servicefrom NimbleGen (Madison, Wiss, USA) using its maskless array synthesis (MAS)technology.  A denser tiling array withshorter oligonucleotides was usually used in NimbleGen's two-step comparativegenome sequencing (CGS) [<xref ref-type="bibr" rid="B2">35</xref>].</p></sec><sec sec-type="subsection" id="sec2.4"><title>2.4. Comparative genome hybridization anddata acquisition</title><p>Comparative genomic hybridizationand signal processing were performed by NimbleGen custom service (NimbleGenSystems Inc., Madison, Wiss, USA). Briefly, GBS DNA from four tester strains and two reference strains werebroken down into separate pools of low molecular weight fragments, labeledindependently with cyanine fluorescent dye and each was hybridized to oneNEM316 and to one 2603VR whole-genome tiling array.  Similar to the Affymetrix chips, the shortoligo GBS arrays were produced by in-slide de novo syntheses.  Like Affymetrixchip hybridization, one slide was used for hybridization per labeled sample.  A total of 12 microarray hybridizations wereperformed.  Genomic hybridization ofNEM316 or 2603VR to its own array served as a signal reference for comparisonswith tester strain hybridizations using the same array.  Genome hybridization of one sequenced genomeagainst the other sequenced genome array was used for validation purposes.  The signal intensity ratios of tester DNA toeach reference DNA were compared to identify probe sequences absent ordifferent from the tester genome.  Theratio was generated by normalizing the signal intensity (setting the medianratio to 1 and the standard deviation to 0.45), dividing the reference by thetester for each strand, and then averaging the two strands.  Signal ratios were plotted as a function of theirgenomic positions and visualized using SignalMap software from NimbleGen.  A custom algorithm was used to mark thepotential variable probe sequence (absent or different in tester genome) basedon comparison to a local threshold (a 1800 bp window).  This analysis was also performed by NimbleGen(see Supplementary Material available at doi:10.1155/2007/14762 for the analyticalalgorithm).</p></sec><sec sec-type="subsection" id="sec2.5"><title>2.5. Additional bioinformatic anddata analysis methods</title><p>Genome-scale sequence comparisonsbetween genomes of NEM316 and 2603VR were performed using GenomeComp [<xref ref-type="bibr" rid="B47">36</xref>].  All strain-specific genetic islands greaterthan 10 bp were identified using run parameters set to 0.01, &#x02212;3, and 1 forexpectation value (e), penalty for a mismatch, and reward for a match,respectively.  To identify matches ofprobe sequences from one fine-tiling oligoarray in the other sequenced genome, a custom Bioperl programwas used for local batch blast analyses. The stand alone BLAST program [<xref ref-type="bibr" rid="B3">37</xref>] for Unixoperation system was used and the percent identity of the best hit for eachprobe within the query genome was determined. All other data analyses were performed using SAS v9.0 (SAS Institute,Inc Cary, NC, USA) and S plus v6.1 (Insightful Corporation, Seattle, Wash, USA).</p></sec><sec sec-type="subsection" id="sec2.6"><title>2.6. GBS library on a slide microarrayconstruction and hybridization</title><p>Werecently developed a new application of microarray technology, called Libraryon a Slide (LOS), for bacterial comparative genomics studies [<xref ref-type="bibr" rid="B52">38</xref>].  LOS technology combines dot blothybridization with the technology of microarrays resulting in glass slides withthousands of bacterial genomes arrayed. Thus libraries of entire genomes rather than the sequence of a singlegenome or set of genes are printed on the slides.  Slides are used to screen large numbers ofstrains for the presence of specific genetic elements of interest. AGBS LOS microarray was created with genomic DNA from 949 GBS isolates sampledfrom a variety of GBS collections and various control strains.  Genomic DNA was isolated using a high-throughputsonication-based method described previously [<xref ref-type="bibr" rid="B49">39</xref>].  DNA from GBS strains along with controls werearrayed in duplicate on Vivid Gene Array slides (Pall Life Sciences, Mich, USA)using a VersArray ChipWriter compact arrayer (Bio-Rad, Calif, USA).  Selected GBS ORFs and four house keepinggenes, (alcohol dehydrogenase (<italic>adhP</italic>),phenylalanyl tRNA synthetase (<italic>pheS</italic>),glutamine synthetase (<italic>glnA</italic>), andglucose kinase (<italic>glcK</italic>)), were PCR-amplifiedfrom either strain NEM316 or 2603VR.  PurifiedPCR products were fluorescein-labeled using BioPrime DNA labeling kit (Invitrogen,Calif, USA).  Each probe was hybridizedwith a different slide overnight at 68&#x000b0;C in PerfectHyb Plus hybridizationbuffer (Sigma, Mo, USA).  After washing, fluorescein-labeledprobes were detected using antiflourescein alkaline phosphatase (Roche,Switzerland) and alkaline phosphatase kit (TeleChem, Calif, USA).  The intensity of each spot was normalized tothe intensity of the quantification probe (a mixture of four housekeepinggenes) to account for differences in DNA concentrations at different spots, andcompared to the intensity of the positive control (sequence strain known tocontain the gene probe) to determine presence/absence of the gene fragment indifferent bacterial strains using previously established methods [<xref ref-type="bibr" rid="B52">38</xref>, <xref ref-type="bibr" rid="B51">40</xref>].</p></sec></sec><sec sec-type="section" id="sec3"><title>3. RESULTS AND DISCUSSION</title><sec sec-type="subsection" id="sec3.1"><title>3.1. Selection of tester strains for comparativegenomic subtraction</title><p>Comparingpathogenic and nonpathogenic strains within a species can provide critical insightsinto bacterial pathogenesis.  However,all sequenced GBS strains are from invasive diseases.  We used molecular epidemiological comparisonsto select representative commensal colonizing GBS isolates for the comparativegenomic hybridization with the highest potential to identify potentialpathogenesis-related genes in sequenced invasive genomes (strains NEM316 and2603VR).  We characterized the diversityof 882 colonizing isolates from a population-based longitudinal study ofhealthy male and nonpregnant female college students [<xref ref-type="bibr" rid="B12">28</xref>] using PFGE andserotyping.  Clustering analysis bydendrogram was performed on these isolates along with a sample of 35 invasiveisolates and sequenced pathogenic strains NEM316 and 2603VR.  Based on this analysis, we selected threecommensal isolates that are genetically distant from the two sequenced genomesbut representative of isolates from relatively large strain clusters that arepredominantly of commensal origin. Isolate 657&#x02013;461 is a serotype V strain representing the largest clonalgroup within our commensal collection. Isolate G617-061 (serotype III) and G293-061 (serotype II) are from twoadditional clusters dominated by colonizing strains.  In addition to these three commensalisolates, one invasive isolate, H-19, was chosen for the comparative genomicsubtraction, because it represents the most common clonal type of the serogroupIa strain in our analysis. Since serotype classification does not necessarily reflect genetic distance among strains [<xref ref-type="bibr" rid="B44">20</xref>], we did not select tester strains based solely on the differences in serotype.  The small number of colonizing stains chosenhere could not and was not intended to capture the diversity of commensalisolates.  It was our first attempt atperforming genome-wide comparisons between colonizing strains and sequenced genomes, so wecould pick gene candidates from a list of several thousands for associationstudy using LOS microarrays where large collections of population-based GBSisolates can be screened.</p></sec><sec sec-type="subsection" id="sec3.2"><title>3.2. Oligonucleotide array validation</title><p>We used shared probesequences within the two genome arrays to assess the reproducibility of thecomparative genomic hybridization and used hybridization of one sequencedgenome against the array of the other sequenced genome to evaluate the accuracyof the array in assessing sequence variation.</p><p>Between184,288 probe pairs on the NEM316 array and 180,020 probe pairs on the 2603VRarray, a total of 16,364 identical probe pairs (32/32 match) wereidentified.  Hybridization results forthis probe subset from two arrays for each tester genome were treated as replicas for accessingthe reproducibility of CGH. Hybridization for each probe was classified as identical or variable inthe tester genome when compared to the reference genome.  The percent concordance for tester genomesG293-061, H1-19, G617-061, and G654-461 were 98.75%, 99.50%, 99.88%, and98.62%, respectively.  Thereproducibility was very high even when the raw signal ratios wereexamined.  The correlation coefficientswere greater than 90% for duplicates.</p><p>Toevaluate the accuracy of the array in assessing sequence variation, we comparedresults from in silicoanalysis with the classificationresults from an actual array hybridization swap between NEM316 and 2603VRgenomes.  Almost all perfectly matchedprobe sequences were correctly identified as identical by hybridization.  Only 4 out of 133,520 and 5 out of 133,570probe sequences were falsely identified as different with NEM316 and 2603VRarrays, respectively.  However, 28,673out of 50,768 (56%) and 25,435 out of 46,450 (55%) mismatched probe sequenceswere falsely identified as identical with NEM316 and 2603VR arrays,respectively.  At the probe level,hybridization has a high sensitivity but low specificity for detectingconserved probe sequences.  Nonetheless, thehigh-density nature of the tiling array still provides overall sequencevariation information at genome and ORF levels. We visually displayed the CGH results by plotting hybridization signalratios of the probes along their genomic positions and compared them with an in silico comparison of NEM316 and2603VR.  The majority of variable probes(i.e., probes with high reference versus tester signal ratios) are clustered primarilyaround strain-specific genetic islands identified by the in silico analysis.  To convert probe-level variation to ORFsequence variation, we calculated the percentage of variable probes for eachORF (number of variable probes identified within an ORF divided by the totalnumber of probes tiling the ORF).  Usingdifferent percentage cutoff values in classifying variable ORFs (divergent orabsent), the CGH-based data was compared with in silico analysis (<xref ref-type="table" rid="tab1">Table 1</xref>). For the NEM 316 array, a 15% cutoff value gave a 2.9% false-negativerate (i.e., ORFs known to be present but classified by hybridization as absentor very divergent) and the best overall sensitivity and specificity (97% and94%, resp.).  For the 2603VRarray, the 20% cutoff point gave the best overall sensitivity and specificity (97%and 91%, resp.).  Thus, these twocutoff points were chosen to classify variable ORFs for the remaining CGHanalyses.</p><p>Comparativegenomic hybridization with fine-tiling 32-mer oligonucleotide microarrays didnot identify all probe sequence variations in the two reference genomes butreliably identified variable ORFs using combined hybridization results of allprobes within each ORF.</p></sec><sec sec-type="subsection" id="sec3.3"><title>3.3. Distribution and mapping of variableprobe sequences</title><p>CGH using NEM316 and 2603VR genomearrays revealed that 3.4&#x02013;15.4% of probe sequences were absent or divergent inthe four tester strains (<xref ref-type="table" rid="tab2">Table 2</xref>).  Thisrange of diversity is similar to the range of sequence differences (5% to 15%)recently observed in pairwise comparison of all eight available complete ordraft GBS genome sequences [<xref ref-type="bibr" rid="B44">20</xref>].  Thetiling arrays allowed a high-resolution view of genome variation amongcomparison strains. <xref ref-type="fig" rid="fig1">Figure 1</xref> displayscomparative hybridization results of tester strains against 2603VR by plottingthe reference to tester signal ratios along their genomic positions.  Although the four tester strains representfour different serotypes (Ia, II, III and V), the majority of absent ordivergent probe sequences in these strains are mapped to the same set ofregions on the NEM316 genome, a serotype III strain.  To a lesser extent, the same set of regionson the 2603VR genome covers the majority of the probes that are absent ordivergent across three of the four tester genomes.  The strain G617-061, a serotype III strain,is very similar to the serotype V reference strain 2603VR genome, with only3.4% probes identified as different compared to  &#x0003e;13% of the other testergenomes.  Comparison of all eightavailable complete or draft GBS genome sequences also demonstrated thatserotype classification does not reflect the genetic diversity of the GBS [<xref ref-type="bibr" rid="B44">20</xref>].  One possible explanation for closely relatedstrains exhibiting different capsules is genetic exchange of genes determiningthe capsular type by horizontal gene transfer.</p></sec><sec sec-type="subsection" id="sec3.4"><title>3.4. NEM316 and 2603VR ORFs absent/divergent intester genomes</title><p>Hybridizationresults from all the probes within each ORF were used to determine the presenceor absence/divergence in the tester genome using the criteria establishedthrough analyzing control experiments (described above).  Among the 2134 ORFs within the NEM316 genome,484 (22.7%) were identified as variable ORFs because they were classified asabsent/divergent in at least one tester genome.  269 (56%) of them were absent/divergent infour tester genomes, and 96, 84, and 35 were classified as absent/divergentin 1, 2, and 3 genomes, respectively.  Of2124 ORFs within the 2603VR genome, 530 (25%) were identified as variable ORFs.  Among them, 81, 121, 162, and 166 wereclassified as absent/divergent in 4, 3, 2, and 1 tester genomes,respectively.  Pairwise genome alignmentof the two reference genomes identified strain-specific regions with a total lengthof 288 kb and 239 kb in NEM316 and 2603VR, respectively.  Greater than 95% of the ORFs residing withinthese strain-specific regions were identified as variable ORFs in our CGH withfour tester genomes, representing 64% (309/484) of NEM316 variable ORFs and 52%(275/530) of the 2603VR variable ORFs. About 80% of variable ORFs identified by CGHare located within fourteen putative pathogenicity islands previouslyidentified in NEM316 [<xref ref-type="bibr" rid="B20">22</xref>].</p><p>Toinvestigate which functional groups these variable ORFs belong to, weclassified ORFs into clusters of orthologous genes (COGs) [<xref ref-type="bibr" rid="B43">41</xref>]. <xref ref-type="fig" rid="fig2">Figure 2</xref> shows the number of variable ORFs ineach COG category.  Approximately half ofthe variable ORFs have not been classified into COGs and are of unknownfunction.  The most common classifiablevariable ORFs belong to the COG category of DNA replication, recombination, andrepair.  This is likely attributable tothe presence of integrated phage or plasmids in the reference genomes.  A large number of variable ORFs are predictedto be involved in transport, regulation, intermediate metabolism, and cell wallmetabolism.  These genes may be importantin maintaining the pathogenic life style and transmission of the invasive GBSstrains.  Genes within these categorieshave also been identified through an invivo study in which signature-tagged mutagenesis and a neonatal ratmodel were used to identify novel GBS genes implicated in virulence [<xref ref-type="bibr" rid="B21">42</xref>].  Relatively few variable ORFs were found to beinvolved in coenzyme transport and metabolism and lipid transport andmetabolism.</p></sec><sec sec-type="subsection" id="sec3.5"><title>3.5. ORFs absent/divergent in at least two testergenomes of commensal origin</title><p>ORFs consistently absent/divergent in commensal tester strains compared to invasivestrains are likely virulence gene candidates. Six ORFs were absent/divergent in all three commensal tester strains,and conserved in the two invasive reference genomes and the invasive testerstrain.  We identified an additional 29ORFs from the reference genomes that were absent/divergent in at least twoout of the three commensal strains (<xref ref-type="table" rid="tab3">Table 3</xref>). Fifteen of these 35 ORFs are predicted hypothetical to be proteins ofunknown function.  Several ORFs arepredicted to be proteins involved in transport, metabolism, and other metabolicfunctions.  Also included are twoputative lipoproteins and two surface proteins. Gene gbs0850 is predicted to encode a fibrinogen binding protein and isidentical to a previously identified <italic>fbsB</italic> gene [<xref ref-type="bibr" rid="B15">43</xref>, <xref ref-type="bibr" rid="B23">44</xref>].  The best match for gbs0850in 2603VR is ORF sag0832, which encodes a different variant of the fibrinogenbinding protein.  ORFs gbs2015 andgbs2016 are two adjacent genes with highly similar DNA sequences predicted toencode glycosyl transferases.  These twogenes are also found together in the 2603VR genome as sag2060 and sag2061.</p><p>Whilewe identified a large number of variable ORFs, few were missing in all three oreven two commensal tester strains. Because multiple genetic factors are involved in GBS virulence andmultiple pathogenesis pathways involving different sets of virulence genes likelyexist, we might expect different sets of virulence genes to be identified whendifferent pairs of invasive and colonizing isolates are compared.</p></sec><sec sec-type="subsection" id="sec3.6"><title>3.6. GBS library on a slide hybridization anddifferentially distributed variable ORFs</title><p>All variable ORFs are potential virulence gene candidates.  Using a novel GBS LOS microarray platformwith a large collection of GBS isolates, the importance of these variable ORFscan be efficiently evaluated. We presentour initial evaluation of 23 of the 35 ORFs identified above using GBSLOS.  We were not able to synthesize goodprobes with strong and specific signals in our initial attempts for the other12 variable ORFs because of their small sizes or poor PCR amplifications.  We therefore left them out of this initialLOS screening.  The GBS LOS microarray containedgenomic DNA from 949 GBS isolates printed in duplicate.  Among them, 386 were isolates from patientswith invasive diseases and 563 were commensal colonizing isolates.  In addition, the LOS array contained DNA fromvarious control strains.  <xref ref-type="table" rid="tab3">Table 3</xref> liststhe prevalence of 23 ORF in the overall GBS collection and their prevalenceratios in invasive strains compared to colonizing strains.  sag2060, sag2061, sag0832, and gbs0474 appearedmore frequently in invasive isolates than in colonizing commensal strains.  By contrast, sag0814 was more frequentlyfound among colonizing isolates than invasive isolates.</p><p>ORFssag2060 and sag2061 are two putative glycosyl transferase genes.  Glycosylation plays an important role in manybiological processes in eukaryotes,  and there is increasing evidence for a roleof glycosylation in bacteria.  Manysurface expressed bacterial structures such as LPS, LOS, capsule, flagella, andpili in pathogenic bacteria are glycosylated [<xref ref-type="bibr" rid="B4">45</xref>&#x02013;<xref ref-type="bibr" rid="B41">47</xref>].  Glycosylation can also be used by bacteria toinactivate antibiotics [<xref ref-type="bibr" rid="B30">48</xref>, <xref ref-type="bibr" rid="B36">49</xref>]. Interestingly, the glycosyl transferase gene <italic>lic2B</italic> in <italic>Haemophilusinfluenzae</italic> was found more frequently among isolates causing otitis mediathan in throat isolates from children [<xref ref-type="bibr" rid="B35">50</xref>]. Future mechanistic studies shouldshed light on the roles of these GBS glycosyl transferases inpathogenesis.</p><p>The sag0832is predicted to encode a fibrinogen binding protein. This gene has been suggested to be an importantvirulence gene for invasive GBS disease. In a murine model of sepsis, the wild-type strain was more virulent thanthe isogenic strain with this gene inactivated [<xref ref-type="bibr" rid="B23">44</xref>].  sag0832 was also shown to promote GBSinvasion into epithelial cells in vitro[<xref ref-type="bibr" rid="B15">43</xref>].  In addition to the three ORFsencoding known proteins, two ORFs (sag0814 and gbs0474) encoding hypotheticalproteins were differentially distributed between invasive and colonizingstrains.  Given the large numbers ofORFs of no known functions that exist in the sequenced genomes, this is notsurprising. Some of these ORFs probablyinvolve complicated traits that are difficult to observe in laboratoryconditions and will be more readily identified using association studies.  Interestingly, sag0814 is found morefrequently in commensal strains than in invasive strains.  It is possible that lack of this geneenhances virulence.  During the processof commensal-to-pathogen evolution, bacteria not only acquire virulence genesbut also shed genes via deletions [<xref ref-type="bibr" rid="B31">51</xref>]. Deletions of genes that facilitate a commensallifestyle could provide an additional evolutionary pathway towards virulence. For example, deletion of lysine decarboxylase genegreatly enhanced the enterotoxin activity in <italic>Shigella</italic> in its evolution [<xref ref-type="bibr" rid="B31">51</xref>]. </p><p>Whilefive out of 23 variable ORFs were differentially distributed between invasiveand commensal isolates, the associations of these ORFs with invasive isolateswere neither exclusive nor strong.  Suchoutcomes were not unexpected for several reasons.  First, we anticipate some degree of randommisclassification to decrease the observed associations because invasive strainscan be also commensal,and noninvasive strains can become opportunistic pathogens.  Second, similar to the existence of severaldistinct pathotypes within many bacterial pathogens, there may be many differentpathotypes within GBS.  One virulencegene may be strongly associated with strains within one specific GBS pathotypebut the association is less pronounced when all invasive isolates are includedin the analysis.  Third, GBS pathogenesisis determined by not one but many virulence genes and any one gene may onlycontribute.  We are in the process of screeningthese and more variable ORFs on an additional 2000 isolates in order to performa more definitive analysis.  In addition,incorporating the population structure of GBS could potentially enhance ouranalysis and help with interpretation.</p><p>Screening23 ORFs against 949 isolates also revealed the striking genome contentdiversity of GBS.  We assigned eachisolate to a genotype based on the presence or absence of all 23 probedexamined.  A total of 503 genotypes wereobserved among 949 isolates.  Using thisclassification, strains with the same PFGE patterns have different genecomposition.  Profiling GBS with alimited number of gene probes could therefore provide a highly discriminativetyping method.</p></sec></sec><sec sec-type="section" id="sec4"><title>4. CONCLUSIONS</title><p>Asincreasing numbers of bacterial genomes are sequenced, postgenome research willfocus on identifying virulence-related genes and the function of thesegenes.  We used a three-step molecularepidemiological approach employing two novel microarray platforms, fine-tiling oligonucleotidemicroarrays, and Library on a Slide to identify bacterial virulence genespotentially contributing to GBS disease. Among hundreds of variable ORFs identified by CGH, 35 were absent/divergent in two of out three commensal test strains but present in twoinvasive reference genomes and a tester invasive strain.  We screened 23 of these ORFs against 949 GBSisolates, and found 5 ORFs that were differentially distributed betweeninvasive and commensal isolates.  Wedemonstrated that this approach can rapidly identify and evaluate bacterialgenes potentially associated with pathogenicity.</p><p>Inour approach, we adopted microarray-based CGH instead of the traditionalgenomic subtraction method to identify genetic differences between pairedcommensal and invasive GBS strains.  Thetraditional genomic subtraction approach can sample only a fraction ofstrain-specific genes.  The high-densitytiling oligonucleotide array-based CGH allowed us to identify the completearray of DNA sequences unique to an invasive compared to a commensal GBSisolate.  A denser and shorteroligonucleotide array design followed by a verification oligonucleotide arraycan be used for identifying even single nucleotide polymorphisms in the genome[<xref ref-type="bibr" rid="B2">35</xref>].  However, CGH-based genomecomparisons depend on the availability of sequenced genomes, and moreover,strain-specific genes identified are confined to the sequenced genome.  We were not able to detect and identifypotential virulence genes that are likely to exist in other unsequencedpathogenic GBS strains.  Given thepan-genome nature of the GBS species where the pool of variable genes areextremely large [<xref ref-type="bibr" rid="B44">20</xref>], future genome comparisons of any two strains are likelyto rely on a cheap and fast direct sequencing approach such as pyrosequencing [<xref ref-type="bibr" rid="B37">52</xref>]. This new approach will eliminate the limitationsof using CGH.</p><p>Oncea set of candidate genes are identified by a genomic comparison, an even morecritical step is to evaluate the role that these genes play in diseasepathogenesis.  This can be done bylarge-scale association studies, bioinformatic prediction, or biologicalfunctional analyses.  Bioinformaticsprediction requires databases with solid structural and functional informationon biological molecules.  Functionalapproaches are often limited to the presence of a characterizable virulencephenotype.  Comparing gene frequenciesamong bacterial isolates collected from different sources, for example, disease-causingand commensal isolates, using statistical association, can provide insight intothe relative importance of a gene sequence in pathogenesis andtransmission.  The number of isolates anddiversity of the collections are important in determining the significance ofobservations made and in ensuring that there is sufficient power to detectassociations.  Large population-basedsamples are required to minimize the identification of spurious associationsthat often arise with small sample comparisons. Including commensal isolates (i.e., nondisease-causing strains) for studyis an integral part of this approach to understand bacterial pathogenesis.  The LOS microarray platform is a robustsystem, adaptable to a wide variety of bacterial pathogens, for detecting thepresence or absence of a candidate gene in thousands of isolates efficiently,thus providing a truly high throughput system to evaluate genes in the postgenomeera.</p></sec><sec sec-type="section" id="supplementary-material-sec"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="f1"><caption><p>NimbleGen uses custom software to identify potential different probe sequences in the tester strains. Briefly, the average reference/tester ratio of both forward and reverse sequence probes was calculated to identify a difference in a probe sequence between tester and reference strains. A threshold for a difference call&#x000e2; was established based on the signals within 1800 bp of the current position. The tester probe sequence is classified to be different from reference if its average signal ratio is greater than the threshold. This process is iterated for all base pairs in the genome to calculate local thresholds for all probe sequences.</p></caption><media xlink:href="314762.f1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This research was supported by NIH Grant R01AI51675 (BF).  We thank Dr. Carol J. Baker of Baylor College of Medicine and Terrence A. Kurzynski of Wisconsin State Laboratory of Hygiene for providing some of the GBS strainsused in this study.  We would like also to thank Maneesh Dave and Elizabeth Marie Levin for help with some of the LOSscreening.</p></ack><ref-list><ref id="B11"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farley</surname><given-names>MM</given-names></name></person-group><article-title>Group B streptococcal disease in nonpregnant adults</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2001</year><volume>33</volume><issue>4</issue><fpage>556</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">11462195</pub-id></element-citation></ref><ref id="B39"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuchat</surname><given-names>A</given-names></name></person-group><article-title>Epidemiology of group B  <italic>streptococcal</italic> disease in the United States: shifting paradigms</article-title><source><italic>Clinical Microbiology Reviews</italic></source><year>1998</year><volume>11</volume><issue>3</issue><fpage>497</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">9665980</pub-id></element-citation></ref><ref id="B40"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuchat</surname><given-names>A</given-names></name></person-group><article-title>Group B <italic>streptococcus</italic></article-title><source><italic>Lancet</italic></source><year>1999</year><volume>353</volume><issue>9146</issue><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10023965</pub-id></element-citation></ref><ref id="B10"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dele Davies</surname><given-names>H</given-names></name><name><surname>Adair</surname><given-names>C</given-names></name><name><surname>McGeer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antibodies to capsular polysaccharides of group B <italic>streptococcus</italic> in pregnant Canadian women: relationship to colonization status and infection in the neonate</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>2001</year><volume>184</volume><issue>3</issue><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">11443553</pub-id></element-citation></ref><ref id="B22"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>N</given-names></name><name><surname>Oliver</surname><given-names>KA</given-names></name><name><surname>Barry</surname><given-names>J</given-names></name><etal/></person-group><article-title>Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B <italic>streptococcus</italic> is independent of capsular serotype</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2006</year><volume>42</volume><issue>7</issue><fpage>915</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">16511753</pub-id></element-citation></ref><ref id="B16"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>LH</given-names></name><name><surname>Elliott</surname><given-names>JA</given-names></name><name><surname>Dwyer</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>1998</year><volume>177</volume><issue>4</issue><fpage>998</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">9534974</pub-id></element-citation></ref><ref id="B24"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachenauer</surname><given-names>CS</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Serotypes VI and VIII predominate among group B <italic>streptococci</italic> isolated from pregnant Japanese women</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>1999</year><volume>179</volume><issue>4</issue><fpage>1030</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">10068604</pub-id></element-citation></ref><ref id="B48"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaleznik</surname><given-names>DF</given-names></name><name><surname>Rench</surname><given-names>MA</given-names></name><name><surname>Hillier</surname><given-names>S</given-names></name><etal/></person-group><article-title>Invasive disease due to group B <italic>streptococcus</italic> in pregnant women and neonates from diverse population groups</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2000</year><volume>30</volume><issue>2</issue><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">10671328</pub-id></element-citation></ref><ref id="B5"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidet</surname><given-names>P</given-names></name><name><surname>Brahimi</surname><given-names>N</given-names></name><name><surname>Chalas</surname><given-names>C</given-names></name><name><surname>Aujard</surname><given-names>Y</given-names></name><name><surname>Bingen</surname><given-names>E</given-names></name></person-group><article-title>Molecular characterization of serotype III Group B-<italic>streptococcus</italic> isolates causing neonatal meningitis</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>2003</year><volume>188</volume><issue>8</issue><fpage>1132</fpage><lpage>1137</lpage><pub-id pub-id-type="pmid">14551882</pub-id></element-citation></ref><ref id="B7"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohnsack</surname><given-names>JF</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Detrick</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Phylogenetic classification of serotype III group B streptococci on the basis of <italic>hylB</italic> gene analysis and DNA sequences specific to restriction digest pattern type III-3</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>2001</year><volume>183</volume><issue>11</issue><fpage>1694</fpage><lpage>1697</lpage><pub-id pub-id-type="pmid">11343222</pub-id></element-citation></ref><ref id="B17"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauge</surname><given-names>M</given-names></name><name><surname>Jespersgaard</surname><given-names>C</given-names></name><name><surname>Poulsen</surname><given-names>K</given-names></name><name><surname>Kilian</surname><given-names>M</given-names></name></person-group><article-title>Population structure of <italic>streptococcus agalactiae</italic> reveals an association between specific evolutionary lineages and putative virulence factors but not disease</article-title><source><italic>Infection and Immunity</italic></source><year>1996</year><volume>64</volume><issue>3</issue><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">8641801</pub-id></element-citation></ref><ref id="B32"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musseer</surname><given-names>JM</given-names></name><name><surname>Mattingly</surname><given-names>SJ</given-names></name><name><surname>Quentin</surname><given-names>R</given-names></name><name><surname>Goudeau</surname><given-names>A</given-names></name><name><surname>Selander</surname><given-names>RK</given-names></name></person-group><article-title>Identification of a high-virulence clone of type III <italic>streptococcus agalactiae</italic> (group B <italic>streptococcus</italic>) causing invasive neonatal disease</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1989</year><volume>86</volume><issue>12</issue><fpage>4731</fpage><lpage>4735</lpage><pub-id pub-id-type="pmid">2660146</pub-id></element-citation></ref><ref id="B42"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Adderson</surname><given-names>EE</given-names></name><name><surname>Nagano</surname><given-names>Y</given-names></name><name><surname>Nagano</surname><given-names>N</given-names></name><name><surname>Briesacher</surname><given-names>MR</given-names></name><name><surname>Bohnsack</surname><given-names>JF</given-names></name></person-group><article-title>Identification of a highly encapsulated, genetically related group of invasive type III group B <italic>streptococci</italic></article-title><source><italic>Journal of Infectious Diseases</italic></source><year>1998</year><volume>177</volume><issue>4</issue><fpage>1116</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">9534996</pub-id></element-citation></ref><ref id="B18"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmig</surname><given-names>R</given-names></name><name><surname>Uldbjerg</surname><given-names>N</given-names></name><name><surname>Boris</surname><given-names>J</given-names></name><name><surname>Kilian</surname><given-names>M</given-names></name></person-group><article-title>Clonal analysis of <italic>streptococcus agalactiae</italic> isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>1993</year><volume>168</volume><issue>4</issue><fpage>904</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">8376836</pub-id></element-citation></ref><ref id="B1"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adderson</surname><given-names>EE</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>DV</given-names></name><name><surname>Bohnsack</surname><given-names>JF</given-names></name></person-group><article-title>Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B <italic>streptococcus agalactiae</italic></article-title><source><italic>Infection and Immunity</italic></source><year>2003</year><volume>71</volume><issue>12</issue><fpage>6857</fpage><lpage>6863</lpage><pub-id pub-id-type="pmid">14638773</pub-id></element-citation></ref><ref id="B19"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>MA</given-names></name><name><surname>Beveridge</surname><given-names>CJE</given-names></name><name><surname>Saunders</surname><given-names>NJ</given-names></name></person-group><article-title>Bacterial virulence factors in neonatal sepsis: group B <italic> streptococous</italic></article-title><source><italic>Current Opinion in Infectious Diseases</italic></source><year>2004</year><volume>17</volume><issue>3</issue><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">15166825</pub-id></element-citation></ref><ref id="B26"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>G</given-names></name><name><surname>St&#x000e5;lhammar-Carlemalm</surname><given-names>M</given-names></name><name><surname>Areschoug</surname><given-names>T</given-names></name></person-group><article-title>Surface proteins of <italic>streptococcus agalactiae</italic> and related proteins in other bacterial pathogens</article-title><source><italic>Clinical Microbiology Reviews</italic></source><year>2005</year><volume>18</volume><issue>1</issue><fpage>102</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">15653821</pub-id></element-citation></ref><ref id="B33"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizet</surname><given-names>V</given-names></name></person-group><article-title>Streptococcal <italic>&#x003b2;</italic>-hemolysins: genetics and role in disease pathogenesis</article-title><source><italic>Trends in Microbiology</italic></source><year>2002</year><volume>10</volume><issue>12</issue><fpage>575</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">12564994</pub-id></element-citation></ref><ref id="B34"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nizet</surname><given-names>V</given-names></name><name><surname>Rubens</surname><given-names>CE</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Fischetti</surname><given-names>VA</given-names></name><name><surname>Novick</surname><given-names>RP</given-names></name><name><surname>Ferretti</surname><given-names>JJ</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name><name><surname>Rood</surname><given-names>JI</given-names></name></person-group><article-title>Pathogenic mechanisms and virulence factors of group B Streptococci</article-title><source><italic>Gram-Positive Pathogens</italic></source><year>2000</year><publisher-loc>Washington, DC, USA</publisher-loc><publisher-name>ASM Press</publisher-name></element-citation></ref><ref id="B44"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tettelin</surname><given-names>H</given-names></name><name><surname>Masignani</surname><given-names>V</given-names></name><name><surname>Cieslewicz</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Genome analysis of multiple pathogenic isolates of <italic>streptococcus agalactiae</italic>: implications for the microbial &#x0201c;pan-genome&#x0201d;</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>39</issue><fpage>13950</fpage><lpage>13955</lpage><pub-id pub-id-type="pmid">16172379</pub-id></element-citation></ref><ref id="B14"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Rusniok</surname><given-names>C</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genome sequence of <italic>streptococcus agalactiae</italic>, a pathogen causing invasive neonatal disease</article-title><source><italic>Molecular Microbiology</italic></source><year>2002</year><volume>45</volume><issue>6</issue><fpage>1499</fpage><lpage>1513</lpage><pub-id pub-id-type="pmid">12354221</pub-id></element-citation></ref><ref id="B20"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>MA</given-names></name><name><surname>Beveridge</surname><given-names>CJE</given-names></name><name><surname>McCormick</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genetic islands of <italic>streptococcus agalactiae</italic> strains NEM316 and 2603VR and their presence in other Group B <italic>Streptococcal</italic> strains</article-title><source><italic>BMC Microbiology</italic></source><year>2005</year><volume>5</volume><fpage>p. 31</fpage></element-citation></ref><ref id="B45"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tettelin</surname><given-names>H</given-names></name><name><surname>Masignani</surname><given-names>V</given-names></name><name><surname>Cieslewicz</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V <italic>streptococcus agalactiae</italic></article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2002</year><volume>99</volume><issue>19</issue><fpage>12391</fpage><lpage>12396</lpage><pub-id pub-id-type="pmid">12200547</pub-id></element-citation></ref><ref id="B50"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Manning</surname><given-names>SD</given-names></name><name><surname>Tallman</surname><given-names>P</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name></person-group><article-title>Molecular epidemiologic approaches to urinary tract infection gene discovery in uropathogenic <italic>Escherichia coli</italic></article-title><source><italic>Infection and Immunity</italic></source><year>2000</year><volume>68</volume><issue>4</issue><fpage>2009</fpage><lpage>2015</lpage><pub-id pub-id-type="pmid">10722596</pub-id></element-citation></ref><ref id="B38"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title>Functional and comparative genomics of pathogenic bacteria</article-title><source><italic>Current Opinion in Microbiology</italic></source><year>2002</year><volume>5</volume><issue>1</issue><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11834364</pub-id></element-citation></ref><ref id="B46"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittam</surname><given-names>TS</given-names></name><name><surname>Bumbaugh</surname><given-names>AC</given-names></name></person-group><article-title>Inferences from whole-genome sequences of bacterial pathogens</article-title><source><italic>Current Opinion in Genetics and Development</italic></source><year>2002</year><volume>12</volume><issue>6</issue><fpage>719</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">12433587</pub-id></element-citation></ref><ref id="B6"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>SJ</given-names></name><name><surname>Manning</surname><given-names>SD</given-names></name><name><surname>Tallman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Group B <italic>streptococcus</italic> colonization in male and nonpregnant female university students: a cross-sectional prevalence study</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2002</year><volume>34</volume><issue>2</issue><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">11740706</pub-id></element-citation></ref><ref id="B12"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Gillespie</surname><given-names>B</given-names></name><name><surname>Manning</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Incidence and duration of group B <italic>streptococcus</italic> by serotype among male and female college students living in a single dormitory</article-title><source><italic>American Journal of Epidemiology</italic></source><year>2006</year><volume>163</volume><issue>6</issue><fpage>544</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">16421237</pub-id></element-citation></ref><ref id="B28"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>SD</given-names></name><name><surname>Pearlman</surname><given-names>MD</given-names></name><name><surname>Tallman</surname><given-names>P</given-names></name><name><surname>Pierson</surname><given-names>CL</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name></person-group><article-title>Frequency of antibiotic resistance among group B <italic>streptococcus</italic> isolated from healthy college students</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2001</year><volume>33</volume><issue>12</issue><fpage>e137</fpage><lpage>e139</lpage><pub-id pub-id-type="pmid">11698992</pub-id></element-citation></ref><ref id="B29"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>SD</given-names></name><name><surname>Tallman</surname><given-names>P</given-names></name><name><surname>Baker</surname><given-names>CJ</given-names></name><name><surname>Gillespie</surname><given-names>B</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name></person-group><article-title>Determinants of co-colonization with group B <italic>streptococcus</italic> among heterosexual college couples</article-title><source><italic>Epidemiology</italic></source><year>2002</year><volume>13</volume><issue>5</issue><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">12192222</pub-id></element-citation></ref><ref id="B27"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>SD</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Pierson</surname><given-names>CL</given-names></name><name><surname>Tallman</surname><given-names>P</given-names></name><name><surname>Baker</surname><given-names>CJ</given-names></name><name><surname>Pearlman</surname><given-names>MD</given-names></name></person-group><article-title>Correlates of antibiotic-resistant group B <italic>streptococcus</italic> isolated from pregnant women</article-title><source><italic>Obstetrics and Gynecology</italic></source><year>2003</year><volume>101</volume><issue>1</issue><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12517649</pub-id></element-citation></ref><ref id="B9"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchardt</surname><given-names>SM</given-names></name><name><surname>DeBusscher</surname><given-names>JH</given-names></name><name><surname>Tallman</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Frequency of antimicrobal resistance among invasive and colonizing Group B Streptococcal isolates</article-title><source><italic>BMC Infectious Diseases</italic></source><year>2006</year><volume>6</volume><fpage>p. 57</fpage></element-citation></ref><ref id="B25"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancefield</surname><given-names>RC</given-names></name><name><surname>McCarty</surname><given-names>M</given-names></name><name><surname>Everly</surname><given-names>WN</given-names></name></person-group><article-title>Multiple mouse protective antibodies directed against group B <italic>streptococci</italic>. Special reference to antibodies effective against protein antigens</article-title><source><italic>Journal of Experimental Medicine</italic></source><year>1975</year><volume>142</volume><issue>1</issue><fpage>165</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">1097573</pub-id></element-citation></ref><ref id="B8"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchardt</surname><given-names>SM</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Chaffin</surname><given-names>DO</given-names></name><etal/></person-group><article-title>Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B <italic>streptococcal</italic> capsular typing</article-title><source><italic>Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>1</issue><fpage>146</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">14715745</pub-id></element-citation></ref><ref id="B2"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>TJ</given-names></name><name><surname>Dailidiene</surname><given-names>D</given-names></name><name><surname>Dailide</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mutation discovery in bacterial genomes: metronidazole resistance in <italic>Helicobacter pylori</italic></article-title><source><italic>Nature Methods</italic></source><year>2005</year><volume>2</volume><issue>12</issue><fpage>951</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">16299480</pub-id></element-citation></ref><ref id="B47"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Z-J</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name></person-group><article-title>GenomeComp: a visualization tool for microbial genome comparison</article-title><source><italic>Journal of Microbiological Methods</italic></source><year>2003</year><volume>54</volume><issue>3</issue><fpage>423</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">12842490</pub-id></element-citation></ref><ref id="B3"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name><name><surname>Schaffer</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title><source><italic>Nucleic Acids Research</italic></source><year>1997</year><volume>25</volume><issue>17</issue><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type="pmid">9254694</pub-id></element-citation></ref><ref id="B52"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Srinivasan</surname><given-names>U</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Gilsdorf</surname><given-names>JR</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name></person-group><article-title>Library on a slide for bacterial comparative genomics</article-title><source><italic>BMC Microbiology</italic></source><year>2004</year><volume>4</volume><fpage>p. 12</fpage></element-citation></ref><ref id="B49"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Gilsdorf</surname><given-names>JR</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name></person-group><article-title>Bacterial genomic DNA isolation for microarray analysis using sonication</article-title><source><italic>BioTechniques</italic></source><year>2005</year><volume>39</volume><issue>5</issue><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">16315370</pub-id></element-citation></ref><ref id="B51"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gillespie</surname><given-names>BW</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name></person-group><article-title>Optimization of a fluorescent-based phosphor imaging dot blot DNA hybridization assay to assess <italic>E. coli</italic> virulence gene profiles</article-title><source><italic>Journal of Microbiological Methods</italic></source><year>2001</year><volume>44</volume><issue>3</issue><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">11240045</pub-id></element-citation></ref><ref id="B43"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatusov</surname><given-names>RL</given-names></name><name><surname>Galperin</surname><given-names>MY</given-names></name><name><surname>Natale</surname><given-names>DA</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name></person-group><article-title>The COG database: a tool for genome-scale analysis of protein functions and evolution</article-title><source><italic>Nucleic Acids Research</italic></source><year>2000</year><volume>28</volume><issue>1</issue><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10592175</pub-id></element-citation></ref><ref id="B21"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AL</given-names></name><name><surname>Knoll</surname><given-names>KM</given-names></name><name><surname>Rubens</surname><given-names>CE</given-names></name></person-group><article-title>Identification of <italic>streptococcus agalactiae</italic> virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis</article-title><source><italic>Molecular Microbiology</italic></source><year>2000</year><volume>37</volume><issue>6</issue><fpage>1444</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">10998175</pub-id></element-citation></ref><ref id="B15"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutekunst</surname><given-names>H</given-names></name><name><surname>Eikmanns</surname><given-names>BJ</given-names></name><name><surname>Reinscheid</surname><given-names>DJ</given-names></name></person-group><article-title>The novel fibrinogen-binding protein FbsB promotes <italic>streptococcus agalactiae</italic> invasion into epithelial cells</article-title><source><italic>Infection and Immunity</italic></source><year>2004</year><volume>72</volume><issue>6</issue><fpage>3495</fpage><lpage>3504</lpage><pub-id pub-id-type="pmid">15155657</pub-id></element-citation></ref><ref id="B23"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>I-M</given-names></name><name><surname>Pietrocola</surname><given-names>G</given-names></name><name><surname>Speziale</surname><given-names>P</given-names></name><name><surname>Verdrengh</surname><given-names>M</given-names></name><name><surname>Tarkowski</surname><given-names>A</given-names></name></person-group><article-title>Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by <italic>streptococcus agalactiae</italic></article-title><source><italic>Journal of Infectious Diseases</italic></source><year>2005</year><volume>192</volume><issue>8</issue><fpage>1456</fpage><lpage>1464</lpage><pub-id pub-id-type="pmid">16170765</pub-id></element-citation></ref><ref id="B4"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benz</surname><given-names>I</given-names></name><name><surname>Schmidt</surname><given-names>MA</given-names></name></person-group><article-title>Never say never again: protein glycosylation in pathogenic bacteria</article-title><source><italic>Molecular Microbiology</italic></source><year>2002</year><volume>45</volume><issue>2</issue><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">12123443</pub-id></element-citation></ref><ref id="B13"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>SK</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Philogene</surname><given-names>MC</given-names></name><name><surname>Alzaharani</surname><given-names>A</given-names></name><name><surname>Rane</surname><given-names>S</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name></person-group><article-title>Pathogenic consequences of <italic>Neisseria gonorrhoeae</italic> pilin glycan variation</article-title><source><italic>Microbes and Infection</italic></source><year>2004</year><volume>6</volume><issue>7</issue><fpage>693</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">15158777</pub-id></element-citation></ref><ref id="B41"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymanski</surname><given-names>CM</given-names></name><name><surname>Wren</surname><given-names>BW</given-names></name></person-group><article-title>Protein glycosylation in bacterial mucosal pathogens</article-title><source><italic>Nature Reviews Microbiology</italic></source><year>2005</year><volume>3</volume><issue>3</issue><fpage>225</fpage><lpage>237</lpage></element-citation></ref><ref id="B30"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name></person-group><article-title>Inactivation of macrolides by producers and pathogens</article-title><source><italic>Current Drug Targets - Infectious Disorders</italic></source><year>2004</year><volume>4</volume><issue>3</issue><fpage>217</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">15379733</pub-id></element-citation></ref><ref id="B36"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quir&#x000f3;s</surname><given-names>LM</given-names></name><name><surname>Carbajo</surname><given-names>RJ</given-names></name><name><surname>Salas</surname><given-names>JA</given-names></name></person-group><article-title>Inversion of the anomeric configuration of the transferred sugar during inactivation of the macrolide antibiotic oleandomycin catalyzed by a macrolide glycosyltransferase</article-title><source><italic>FEBS Letters</italic></source><year>2000</year><volume>476</volume><issue>3</issue><fpage>186</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">10913610</pub-id></element-citation></ref><ref id="B35"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettigrew</surname><given-names>MM</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><name><surname>Marrs</surname><given-names>CF</given-names></name><name><surname>Gilsdorf</surname><given-names>JR</given-names></name></person-group><article-title>Identification of the lipooligosaccharide biosynthesis gene <italic>lic2B</italic> as a putative virulence factor in strains of nontypeable <italic>Haemophilus influenzae</italic> that cause otitis media</article-title><source><italic>Infection and Immunity</italic></source><year>2002</year><volume>70</volume><issue>7</issue><fpage>3551</fpage><lpage>3556</lpage><pub-id pub-id-type="pmid">12065495</pub-id></element-citation></ref><ref id="B31"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurelli</surname><given-names>AT</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>RE</given-names></name><name><surname>Bloch</surname><given-names>CA</given-names></name><name><surname>Rode</surname><given-names>CK</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title>&#x0201c;Black holes&#x0201d; and bacterial pathogenicity: a large genomic deletion that enhances the virulence of <italic>Shigella</italic> spp. and enteroinvasive <italic>Escherichia coli</italic></article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1998</year><volume>95</volume><issue>7</issue><fpage>3943</fpage><lpage>3948</lpage><pub-id pub-id-type="pmid">9520472</pub-id></element-citation></ref><ref id="B37"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronaghi</surname><given-names>M</given-names></name></person-group><article-title>Pyrosequencing sheds light on DNA sequencing</article-title><source><italic>Genome Research</italic></source><year>2001</year><volume>11</volume><issue>1</issue><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11156611</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Locations of variable probes sequences identified within genomes of group B <italic>Streptococcus</italic> strains 2603VR in comparative genomic hybridization using each of the four tester strains of group B <italic>Streptococcus</italic>.</p></caption><graphic xlink:href="IPID2008-314762.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Number of variable open reading frames in group B <italic>Streptococcus</italic> strains NEM316 and 2603VR classified in each of the clusters of orthologous genes (COG) category plus those not classified in COG database.</p></caption><graphic xlink:href="IPID2008-314762.002"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Sensitivity (probability open reading frame is detected, given it is truly present) and specificity assessments (probability open reading frame is not detected, given it is not present) of different cutoff values in classifying variable open reading frames using fine-tiling oligonucleotide genome arrays created from the genomic sequence of group B <italic>Streptococcus</italic> strains NEM316 and 2603VR.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Reference  genome</th><th align="center" rowspan="1" colspan="1">Percentage  cutoff point</th><th align="center" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1">Specificity</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">NEM316</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.91</td></tr><tr><td align="center" rowspan="1" colspan="1">15%</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.96</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="3" colspan="1">2603VR</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">0.91</td></tr><tr><td align="center" rowspan="1" colspan="1">15%</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.96</td></tr></tbody></table></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>Number (percentage) of variable probe sequences among four tester group B <italic>Streptococcus</italic> genomes using sequenced strains as a reference revealed by comparative genomic hybridization.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Reference/sequenced genomes of invasive isolates</th><th align="center" rowspan="1" colspan="1">H1-19 (Ia) (invasive)</th><th align="center" rowspan="1" colspan="1">G293-061 (II) (commensal)</th><th align="center" rowspan="1" colspan="1">G617-061 (III) (commensal)</th><th align="center" rowspan="1" colspan="1">G654-461 (V) (commensal)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">2603VR</td><td align="center" rowspan="1" colspan="1">327 (15.4%)</td><td align="center" rowspan="1" colspan="1">320 (15.1%)</td><td align="center" rowspan="1" colspan="1">72 (3.4%)</td><td align="center" rowspan="1" colspan="1">278 (13.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NEM316</td><td align="center" rowspan="1" colspan="1">277 (13.0%)</td><td align="center" rowspan="1" colspan="1">305 (14.3%)</td><td align="center" rowspan="1" colspan="1">305 (14.3%)</td><td align="center" rowspan="1" colspan="1">271 (12.7%)</td></tr></tbody></table></table-wrap><table-wrap id="tab3" position="float"><label>Table 3</label><caption><p>Open reading frames (ORF) present in invasive strains but absent at least in two out of three commensal tester group B <italic>Streptococcus</italic> strains by comparative genomic hybridization and their presence among 949 GBS isolates and their prevalence ratio between invasive (<italic>n</italic> = 386) and colonizing (<italic>n</italic> = 563) isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> ORF </th><th align="center" rowspan="1" colspan="1"> Probe-positive strains (%) </th><th align="center" rowspan="1" colspan="1"> Prevalence ratio (95% CI)<sup>(a)</sup></th><th align="left" rowspan="1" colspan="1"> Predicted  protein </th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">sag0004</td><td align="center" rowspan="1" colspan="1">524 (55%)</td><td align="center" rowspan="1" colspan="1">1.1 (0.96&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0005</td><td align="center" rowspan="1" colspan="1">706 (74%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.93&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0027</td><td align="center" rowspan="1" colspan="1">941 (99%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.98&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">phosphoribosylaminoimidazole synthetase </td></tr><tr><td align="left" rowspan="1" colspan="1">sag0175</td><td align="center" rowspan="1" colspan="1">692 (73%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.93&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0206</td><td align="center" rowspan="1" colspan="1">590 (62%)</td><td align="center" rowspan="1" colspan="1">0.9 (0.82&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">lipoprotein, putative</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0253</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">acetyltransferase, GNAT family</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0414</td><td align="center" rowspan="1" colspan="1">927 (98%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.97&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">phosphorylase, Pnp/Udp family, putative</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0426</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">cupin family protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0427</td><td align="center" rowspan="1" colspan="1">517 (54%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.93&#x02013;1.17)</td><td align="left" rowspan="1" colspan="1">transcriptional regulator, MerR family</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0700</td><td align="center" rowspan="1" colspan="1">925 (97%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.97&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0814</td><td align="center" rowspan="1" colspan="1">117 (12%)</td><td align="center" rowspan="1" colspan="1">0.6 (0.39&#x02013;0.83)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0815</td><td align="center" rowspan="1" colspan="1">364 (38%)</td><td align="center" rowspan="1" colspan="1">0.9 (0.76&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">transcriptional regulator, Cro/CI family-related protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag0832</td><td align="center" rowspan="1" colspan="1">371 (39%)</td><td align="center" rowspan="1" colspan="1">1.5 (1.29&#x02013;1.77)</td><td align="left" rowspan="1" colspan="1">fibrinogen binding protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1130</td><td align="center" rowspan="1" colspan="1">367 (39%)</td><td align="center" rowspan="1" colspan="1">1.1 (0.90&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1140</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1207</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1781</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">primase-related protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1968</td><td align="center" rowspan="1" colspan="1">87 (9%)</td><td align="center" rowspan="1" colspan="1">1.1 (0.71&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1969</td><td align="center" rowspan="1" colspan="1">907 (96%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.97&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">ribosomal protein L11 methyltransferase</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1974</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">MutT/nudix family protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1975</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1976</td><td align="center" rowspan="1" colspan="1">290 (31%)</td><td align="center" rowspan="1" colspan="1">0.9 (0.73&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1994</td><td align="center" rowspan="1" colspan="1">289 (30%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.82&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag1999</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2021</td><td align="center" rowspan="1" colspan="1">395 (42%)</td><td align="center" rowspan="1" colspan="1">1.2 (1.00&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1">cell wall surface anchor family protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2026</td><td align="center" rowspan="1" colspan="1">224 (24%)</td><td align="center" rowspan="1" colspan="1">1.1 (0.88&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">membrane protein, putative</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2027</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">ABC transporter, ATP-binding protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2028</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2045</td><td align="center" rowspan="1" colspan="1">364 (38%)</td><td align="center" rowspan="1" colspan="1">1.1 (0.90&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1">DNA topology modulation protein FlaR, putative</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2057</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">leucyl-tRNA synthetase</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2060</td><td align="center" rowspan="1" colspan="1">427 (45%)</td><td align="center" rowspan="1" colspan="1">1.3 (1.13&#x02013;1.50)</td><td align="left" rowspan="1" colspan="1">glycosyl transferase, family 8</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2061</td><td align="center" rowspan="1" colspan="1">437 (46%)</td><td align="center" rowspan="1" colspan="1">1.2 (1.07&#x02013;1.41)</td><td align="left" rowspan="1" colspan="1">glycosyl transferase, family 8</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2088</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="center" rowspan="1" colspan="1">(b)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="left" rowspan="1" colspan="1">sag2147</td><td align="center" rowspan="1" colspan="1">687 (72%)</td><td align="center" rowspan="1" colspan="1">1.0 (0.9&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">lipoprotein, putative</td></tr><tr><td align="left" rowspan="1" colspan="1">gbs0474<sup>(c)</sup></td><td align="center" rowspan="1" colspan="1">270 (28%)</td><td align="center" rowspan="1" colspan="1">1.5 (1.21&#x02013;1.80)</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr></tbody></table><table-wrap-foot><fn><p>												<sup>(a)</sup>Prevalence with confidence interval not overlapping 1 are considered statistical significant.</p></fn><fn><p>												<sup>(b)</sup>These ORFs were not screened using LOS mostly because of small sizes.</p></fn><fn><p>												<sup>(c)</sup>Exact corresponding gene in strain 2603VR was not found by blast search while it was classified as present in 2603 VR by CGH.</p></fn></table-wrap-foot></table-wrap></floats-group></article>